Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$46.53 - $55.17 $292,208 - $346,467
-6,280 Reduced 42.49%
8,500 $446,000
Q2 2022

Aug 02, 2022

BUY
$46.53 - $55.17 $292,208 - $346,467
6,280 Added 73.88%
14,780 $775,000
Q1 2022

May 13, 2022

SELL
$45.75 - $56.69 $83,493 - $103,459
-1,825 Reduced 17.68%
8,500 $440,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $408,035 - $604,843
9,875 Added 2194.44%
10,325 $610,000
Q3 2018

Nov 14, 2018

SELL
$34.47 - $41.81 $20,682 - $25,086
-600 Reduced 57.14%
450 $20,000
Q2 2018

Aug 03, 2018

BUY
$32.98 - $35.16 $3,957 - $4,219
120 Added 12.9%
1,050 $38,000
Q1 2018

May 02, 2018

SELL
$31.91 - $37.02 $13,083 - $15,178
-410 Reduced 30.6%
930 $33,000
Q4 2017

Feb 05, 2018

SELL
$33.26 - $35.29 $80,555 - $85,472
-2,422 Reduced 64.38%
1,340 $49,000
Q3 2017

Oct 30, 2017

SELL
$31.0 - $34.15 $118,978 - $131,067
-3,838 Reduced 50.5%
3,762 $134,000
Q2 2017

Aug 10, 2017

BUY
N/A
7,600
7,600 $255,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.